APPLICATION
ANDA204532
TYPE
ANDA
ORIGINAL APPROVAL
2017-01-10
LATEST ACTION
2021-06-23
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Discontinued
Products
OLOPATADINE HYDROCHLORIDEDiscontinued
OLOPATADINE HYDROCHLORIDE EQ 0.1% BASE · SOLUTION/DROPS · OPHTHALMIC
Approval history
2021-06-23Labeling · Supplement 4 · standardAP
2017-01-10UNKNOWN · OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.